PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
von Boehmer, H.* ; Daniel, C.

Therapeutic opportunities for manipulating TReg cells in autoimmunity and cancer.

Nat. Rev. Drug Discov. 12, 51-63 (2013)
Verlagsversion Volltext DOI PMC
Closed
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Forkhead box P3 (FOXP3)-expressing regulatory T (T-Reg) cells have a pivotal role in the regulation of immune responses and in the maintenance of immunological self-tolerance. These cells have emerged as attractive targets for strategies that allow the steering of immune responses in desired directions-arming the immune system to destroy infected cells and cancer cells or downregulating it to limit tissue destruction in autoimmunity. Efforts to understand the generation, activation and function of T-Reg cells should permit the development of therapeutics for reprogramming the immune system. In this Review, we discuss insights into the generation of T-Reg cells, their involvement in disease and the molecular basis of the dominant tolerance exerted by FOXP3(+) T-Reg cells that could permit their safe and specific manipulation in humans.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
33.078
5.973
130
148
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Versus-host-disease ; Ligase Cbl-b ; Nf-kappa-b ; In-vivo ; Foxp3 Expression ; Regulatory Cells ; Immune-response ; Nod Mice ; Antitumor Immunity ; Peripheral-blood
Sprache englisch
Veröffentlichungsjahr 2013
HGF-Berichtsjahr 2013
ISSN (print) / ISBN 1474-1776
Zeitschrift Nature Reviews - Drug Discovery
Quellenangaben Band: 12, Heft: 1, Seiten: 51-63 Artikelnummer: , Supplement: ,
Verlag Nature Publishing Group
Verlagsort London
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Diabetes Research (IDF)
POF Topic(s) 30502 - Diabetes: Pathophysiology, Prevention and Therapy
Forschungsfeld(er) Helmholtz Diabetes Center
PSP-Element(e) G-552200-002
PubMed ID 23274471
DOI 10.1038/nrd3683
WOS ID WOS:000312987000015
Erfassungsdatum 2013-02-01
[➜Korrektur melden]